Mika Gissler
Auto-generated profile, based on publicly available information

Mika Gissler

Department of Data and Analytics THL Finnish Institute for Health and Welfare Helsinki Finland

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
DBDan Bai
Dan Bai
BYBenjamin Hon Kei Yip
Benjamin Hon Kei Yip
GWGayle C. Windham
Gayle C. Windham
ASAndre Sourander
Andre Sourander
RFRichard Francis
Richard Francis
SSSven Sandin
Sven Sandin
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in social interaction and communication and the presence of restricted interests and repetitive behaviors.1,2

25 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MNMerete Nordentoft
Merete Nordentoft
KWKristian Wahlbeck
Kristian Wahlbeck
JHJonas Hällgren
Jonas Hällgren
JWJeanette Westman
Jeanette Westman
UOUrban Osby
Urban Osby
TLThomas Munk Laursen
Thomas Munk Laursen
Excess mortality among patients with severe mental disorders has not previously been investigated in detail in large complete national populations. To investigate the excess mortality in different diagnostic categories due to suicide and other external causes of death, and due to specific causes in connection with diseases and medical conditions. In longitudinal national psychiatric case registers from Denmark, Finland, and Sweden, a cohort of 270,770 recent-onset patients, who at least once during the period 2000 to 2006 were admitted due to a psychiatric disorder, were followed until death or the end of 2006. They were followed for 912,279 person years, and 28,088 deaths were analyzed. Life expectancy and standardized cause-specific mortality rates were estimated in each diagnostic group in all three countries. The life expectancy was generally approximately 15 years shorter for women and 20 years shorter for men, compared to the general population. Mortality due to diseases and medical conditions was increased two- to three-fold, while excess mortality from external causes ranged from three- to 77-fold. Mortality due to diseases and medical conditions was generally lowest in patients with affective disorders and highest in patients with substance abuse and personality disorders, while mortality due to suicide was highest in patients with affective disorders and personality disorders, and mortality due to other external causes was highest in patients with substance abuse. These alarming figures call for action in order to prevent the high mortality.

1 December 2011 in The British Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
KWKristian Wahlbeck
Kristian Wahlbeck
JWJeanette Westman
Jeanette Westman
MNMerete Nordentoft
Merete Nordentoft
MGMika Gissler
Mika Gissler
TLThomas Munk Laursen
Thomas Munk Laursen
Background: People with mental disorders evince excess mortality due to natural and unnatural deaths. The relative life expectancy of people with mental disorders is a proxy measure of effectiveness of social policy and health service provision.Aims: To evaluate trends in health outcomes of people with serious mental disorders.Method: We examined nationwide 5-year consecutive cohorts of people admitted to hospital for mental disorders in Denmark, Finland and Sweden in 1987–2006. In each country the risk population was identified from hospital discharge registers and mortality data were retrieved from cause-of-death registers. The main outcome measure was life expectancy at age 15 years.Results: People admitted to hospital for a mental disorder had a two- to threefold higher mortality than the general population in all three countries studied. This gap in life expectancy was more pronounced for men than for women. The gap decreased between 1987 and 2006 in these countries, especially for women. The notable exception was Swedish men with mental disorders. In spite of the positive general trend, men with mental disorders still live 20 years less, and women 15 years less, than the general population.Conclusions: During the era of deinstitutionalisation the life expectancy gap for people with mental disorders has somewhat diminished in the three Nordic countries. Our results support further development of the Nordic welfare state model, i.e. tax-funded community-based public services and social protection. Health promotion actions, improved access to healthcare and prevention of suicides and violence are needed to further reduce the life expectancy gap.

27 July 2014 in Human Reproduction
Verified
Journal Article
Open access
PDF file
MKM. S. Kupka
M. S. Kupka
AFA. P. Ferraretti
A. P. Ferraretti
JMJ. de Mouzon
J. de Mouzon
JCJ. A. Castilla
J. A. Castilla
VGV. Goossens
V. Goossens
T(The European Ivf-Monitoring (Eim)
The European Ivf-Monitoring (Eim)
The 14th European IVF—monitoring (EIM) report presents the results of medically assisted reproduction treatments including assisted reproductive technology (ART) cycles and intrauterine insemination (IUI) cycles initiated in Europe during 2010: are there changes in the trends compared with previous years? Despite some fluctuations in the number of countries reporting, the overall number of ART cycles has continued to increase year by year, and while pregnancy rates in 2010 remained similar to those reported in 2009, the number of transfers with multiple embryos (three or more) further declined. Since 1997, ART data in Europe have been collected and reported in 13 manuscripts, published in Human Reproduction. Retrospective collection of European ART data by the EIM Consortium for ESHRE; data were collected from cycles started between 1st January and 31st December 2010 by the National Registries of individual European countries, or on a voluntary basis by personal information for European countries without a national registry. Out of 31 countries, 991 clinics reported 550 296 ART treatment cycles: IVF (125 994), ICSI (272 771), frozen embryo replacement (FER, 114 593), egg donation (ED, 25 187), in vitro maturation (493), preimplantation genetic diagnosis/preimplantation genetic screening (6399) and frozen oocyte replacements (4859). European data on IUI using husband/partner's semen (IUI-H) or donor semen (IUI-D) were reported from 22 and 19 countries, respectively. A total of 176 512 IUI-H (+8.4% compared with 2009) and 38 124 IUI-D (+30.4% compared with 2009) cycles were included. In 16 countries where all clinics reported to the national ART registry, a total of 267 120 ART cycles were performed in a population of 219 million inhabitants, corresponding to 1221 cycles per million inhabitants. For IVF, the clinical pregnancy rates per aspiration and per transfer increased to 29.2 and 33.2%, respectively, and for ICSI, the corresponding rates also increased to 28.8 and 32.0%, when compared with the rates of 2009. In FER cycles, the pregnancy rate per thawing was 20.3%; in ED cycles the pregnancy rate per fresh transfer was 47.4% and per thawed transfer 33.3%. The delivery rate after IUI-H was 8.9 and 13.8% after IUI-D. In IVF and ICSI cycles, one, two, three and four or more embryos were transferred in 25.7, 56.7, 16.1 and 1.5%, respectively. The proportions of singleton, twin and triplet deliveries after IVF and ICSI (combined) were 79.4, 19.6 and 1.0%, respectively, resulting in a total multiple delivery rate of 20.6% compared with 20.2% in 2009, 21.7% in 2008, 22.3% in 2007, 20.8% in 2006. In FER cycles, the multiple delivery rate was 12.8% (12.5% twins and 0.3% triplets). Twin and triplet delivery rates associated with IUI cycles were 9.6/0.5 and 8.5/0.2%, following treatment with husband and donor semen, respectively. The method of reporting is not standardized in Europe but varies among countries. Furthermore registries from a number of countries have been unable to provide some of the relevant data such as initiated cycles and deliveries. Therefore, results should be interpreted with caution. The 14th ESHRE report on ART and IUI treatments shows a continuing expansion of the number of ART treatment cycles in Europe, with more than half a million of cycles reported in 2010. The use of ICSI may have reached a plateau. When compared with 2009/2008, pregnancy and (multiple) delivery rates after IVF and ICSI remained relatively stable. The number of multiple embryo transfers (three or more embryos) has shown a decline. The study has no external funding; all costs are covered by ESHRE. There are no competing interests.

29 July 2015 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Closed access
PDF file
LTL Thurn
L Thurn
PLPelle G. Lindqvist
Pelle G. Lindqvist
MJM Jakobsson
M Jakobsson
LCLb Colmorn
Lb Colmorn
KKK Klungsoyr
K Klungsoyr
KKK Källen
K Källen

5 July 2013 in Human Reproduction
Verified
Journal Article
Open access
PDF file
UWUlla-Britt Wennerholm
Ulla-Britt Wennerholm
AHAnna-Karina Aaris Henningsen
Anna-Karina Aaris Henningsen
LRLiv Bente Romundstad
Liv Bente Romundstad
CBChristina Bergh
Christina Bergh
APAnja Pinborg
Anja Pinborg
ATAila Tiitinen
Aila Tiitinen
What are the risks of adverse outcomes in singletons born after frozen-thawed embryo transfer (FET)? Singletons born after FET have a better perinatal outcome compared with singletons born after fresh IVF and ICSI as regards low birthweight (LBW) and preterm birth (PTB), but a worse perinatal outcome compared with singletons born after spontaneous conception. Previous studies have shown a worse perinatal outcome in children born after IVF in general compared with children born after spontaneous conception. In singletons born after FET, a lower rate of PTB and LBW and a higher rate of large for gestational age (LGA) compared with singletons born after fresh IVF have been shown. A retrospective Nordic population-based cohort study of all singletons conceived after FET in Denmark, Norway and Sweden until December 2007 was performed. Singletons born after FET (n = 6647) were compared with a control group of singletons born after fresh IVF and ICSI (n = 42 242) and singletons born after spontaneous conception (n = 288 542). Data on perinatal outcomes were obtained by linkage to the national Medical Birth Registries. Odds ratios were calculated for several perinatal outcomes and adjustments were made for maternal age, parity, year of birth, offspring sex and country of origin. Singletons born after FET had a lower risk of LBW (adjusted odds ratio (aOR) 0.81, 95% confidence interval (CI) 0.71–0.91), PTB (aOR 0.84, 95% CI 0.76–0.92), very PTB (VPTB; aOR 0.79, 95% CI 0.66–0.95) and small for gestational age (SGA; aOR 0.72, 95% CI 0.62–0.83), but a higher risk of post-term birth (aOR 1.40, 95% CI 1.27–1.55), LGA (aOR 1.45, 95% CI 1.27–1.64), macrosomia (aOR 1.58, 95% CI 1.39–1.80) and perinatal mortality (aOR 1.49, 95% CI 1.07–2.07) compared with singletons born after fresh IVF and ICSI. Compared with children conceived after spontaneous conception, singletons born after FET had a higher risk of LBW (aOR 1.27, 95% CI 1.13–1.43), very LBW (aOR 1.69, 95% CI 1.33–2.15), PTB (aOR 1.49, 95% CI 1.35–1.63), VPTB (aOR 2.68, 95% CI 2.24–3.22), SGA (aOR 1.18, 95% CI 1.03–1.35), LGA (aOR 1.29, 95% CI 1.15–1.45), macrosomia (aOR 1.29, 95% CI 1.15–1.45) and perinatal (aOR 1.39, 95% CI 1.03–1.87) neonatal (aOR 1.87, 95% CI 1.23–2.84) and infant mortality (aOR 1.92, 95% CI 1.36–2.72). When analyzing trends over time, the risk of being born LGA increased over time for singletons born after FET compared with singletons born after fresh IVF and ICSI (P = 0.04). As in all observational studies, the possible role of residual confounding factors and bias should be considered. In this study, we were not able to control for confounding factors, such as BMI, smoking and reason for, or length of, infertility. Perinatal outcomes in this large population-based cohort of children born after FET from three Nordic countries compared with fresh IVF and ICSI and spontaneous conception were in agreement with the literature. No conflict of interest was reported. The study was supported by grants from the ALF agreement at the Sahlgrenska University Hospital, Gothenburg, Sweden. The European Society for Human Reproduction and Embryology (ESHRE), the University of Copenhagen, Denmark, and the Danish Agency for Science, Technology and Innovation have also supported the project. The CoNARTaS group has received travel and meeting funding from the Nordic Society of Obstetrics and Gynecology (NFOG).